Show results for
Refine by
Macular Suppliers Serving Marshall Islands
35 companies found
based inPaju-si, SOUTH KOREA
Welcome to IDS group, a company dedicated to the top priority satisfaction. As a global leading manufacturer in Aesthetic, Surgical, Dental, Cosmetic and Veterinary, we are specialized in manufacturing for Multiple function of lasers which can use ...
Provides high power output during all the pigment procedures. Consistent output on a large targeted area with uniform energy distribution allows safe and effective treatment, minimizing skin thermal injury and selectively destroying pigments ...
based inYuseong-gu, SOUTH KOREA
Established in 2002 with technical expertise recognized both internally and externally, ours is a professional company specializing in medical equipment for optics. We are specialized in Auto Refractor Keratometer, Chart projector, Auto Lensmeter & ...
High Definition LCD Smart Chart System. Wide range of test. FULL-HD Video ...
based inAlcobendas, SPAIN
AlgaEnergy is a leading biotechnology-based company in the sector of the microalgae culture, that has promoted or is sharing powerful R&I programs, whose results already ensure the reliability of its biological processes and a high performance in ...
based inCoralville, IOWA (USA)
In April 2018, Digital Diagnostics(formerly known as IDx) became the first company to ever receive FDA clearance for an AI diagnostic platform that makes a diagnosis without physician input at the point-of-care. This achievement did not happen ...
IDx-DR is an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy (including macular ...
based inMarlborough, MASSACHUSETTS (USA)
When a five-year-old boy was blinded after a regular eye exam failed to spot a retinal detachment, his father made it his life™s work to help eye care professionals by revolutionising retinal imaging. Optos was founded by Douglas Anderson with the ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
PMC-403 is a monoclonal antibody that targets the human TIE2 that regulate the angiogenesis and vessel maturation in endothelial cells. It binds to TIE2 expressing endothelial cells and normalize VEGF-induced pathological leaky blood vessels in eyes ...
based inTucson, ARIZONA (USA)
Novel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better ...
RGNXXXX is a potent, topical eye drop for the treatment of wet AMD. The anti-neovascular effects reduces leaky blood vessels in the ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Reproxalap (ADX-102) is an active aldehyde sequestering agent that's being researched for dry eye syndrome, allergic conjunctivitis, and non-infectious anterior uveitis. Reproxalap has anti-inflammatory and pain-relieving ...
based inHeerlen, NETHERLANDS
DSM is a global purpose-led, science-based company specializing in Nutrition, Health & Sustainable Living. Our purpose is to create brighter lives for all. We achieve it by using all the scientific and innovation power at our disposal to tackle some ...
Discover our implantable drug delivery systems made of bioresorbable polymers that release precise quantities of therapeutic agents gradually over time. DSM is a global leader in biomedical materials science – experience that we are now using ...
based inDepew, NEW YORK (USA)
Reichert Technologies, based in Buffalo, New York, is a global leader in designing, engineering, and manufacturing high-quality diagnostic devices and equipment for ophthalmologists, optometrists, opticians, and retail eye centers. Inventor of ...
based inSan Francisco, CAMBODIA
Verana Health is a digital health company that delivers quality drug lifecycle, medical practice, and medical society insights from an exclusive real-world data network of more than 20,000 healthcare providers. Our specialty medical society partners ...
based inCarlsbad, CALIFORNIA (USA)
The Global Leader in Human Trophoblast Stem Cells [hTSCs] for Allogeneic Cell Therapies. Accelerated Biosciences is a regenerative medicine company. We are sourcing the highest quality immune-privileged human Trophoblast Stem Cells (hTSCs) with no ...
Stem cells possess two defining characteristics that give potential to address unmet medical needs in healthcare: 1) the ability to self-replicate throughout the life of an organism and 2) the ability to differentiate to many different cell types in ...
based inWetzlar, GERMANY
Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. Widely recognized for optical precision and innovative technology, the company is one of the market leaders ...
based inManassas, VIRGINIA (USA)
Notal Vision is the first diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes. By applying artificial intelligence (AI)-driven data interpretation to the unprecedented high volumes of ...
Notal Vision is developing a first-of-its-kind Artificial Intelligence-enabled digital diagnostic for patients with neovascular retina diseases using our patient-operated Home Optical Coherence Tomography device. The first disease in the Notal Home ...
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
Preserving or restoring eyesight has the power to change a patient’s life. Avania’s ophthalmology team works with you to advance your important research that is necessary for better eye health. From medical technologies to medical ...
based inLowell, MASSACHUSETTS (USA)
Diagnosys is an inventor-owned private company devoted to the field of ophthalmic electrophysiology. Founded in 1983 as Doran Instruments, this company invented the Maculoscope, a focal ERG system that is the predicate device for most of the ...
The Dark Adaptometry module uses the ColorDome™ or ColorFlash™ stimulator to perform a full or partial field dark adaptation to accurately measure retinal parameters such as cone sensitivity, rod sensitivity and the rod-cone break point. ...
based inMiddletown, PENNSYLVANIA (USA)
MacuLogix is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage age-related macular degeneration (AMD) patients early, before irreversible vision loss has occurred. We can help ...
Backed by 20 years of proven clinical research, the AdaptDx Pro® is a revolutionary new way to test patients. Advanced, precision eye tracking technology automatically aligns with the eye to capture an accurate measurement of dark adaptation ...
based inMarlborough, MASSACHUSETTS (USA)
IPG Photonics is the inventor and world’s leading producer of high-power fiber lasers, which enable greater precision, higher speed processing, more flexible production methods and enhanced productivity. IPG has a rich history of innovation, ...
Historically, ophthalmology was the first medical field where lasers have found an application. Over more than five decades, use of lasers in ophthalmology has successfully shown effective and safe results in treating various eye conditions. Whether ...
based inWaltham, MASSACHUSETTS (USA)
Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases. Existing therapies for retinal neovascular / exudative diseases have made great ...
With high affinity for VEGF and heparan sulfate proteoglycans, TH103 potentially increases intraocular retention, thereby minimizing injection frequency. Ongoing Phase 1 clinical trials for neovascular age-related macular ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...